Galapagos
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Galapagos
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.
Others were interested in
See all stocksFrequently asked questions
To buy Galapagos stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Galapagos by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Galapagos is GLPG:xams. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Galapagos has its primary listing on Euronext Amsterdam. You can trade Galapagos with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Galapagos is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Galapagos as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Galapagos.